Due to the growing demand for GLP-1s to help employees lose weight, employers experienced an 8.4% increase in pharmacy benefit costs last year. This pushed organizations to increase their health plan budgets by 5.2% in 2024. While these medications are effective for weight loss, employers are grappling with a critical decision–whether or not to provide coverage.
Successfully treating obesity does not hinge on this class of so-called miracle drugs alone. There are a variety of alternative anti-obesity medications (AOMs) that are both effective treatments and less expensive. When combined with approaches like step therapy, a broader medication toolkit can help employers unlock the full value of their benefits strategy.
In this webinar, Dr. Rekha Kumar, MD, MS, Chief Medical Officer at Found share:
- An introduction to alternative AOMs and step therapy
- How to establish effective GLP-1 cost control measures
- The importance of comprehensive weight care to drive effective weight loss
- A real-world example of how to improve employees' overall health
